 Qin Yang
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saliva | 3 | 2023 | 242 | 1.520 |
Why?
| | Virus Assembly | 6 | 2020 | 78 | 1.410 |
Why?
| | Bacteriophage lambda | 8 | 2022 | 88 | 1.390 |
Why?
| | Carrier State | 2 | 2021 | 67 | 1.360 |
Why?
| | Genome, Viral | 5 | 2020 | 144 | 1.280 |
Why?
| | Virology | 1 | 2024 | 24 | 0.860 |
Why?
| | Orthomyxoviridae | 1 | 2024 | 40 | 0.840 |
Why?
| | Dengue Virus | 1 | 2024 | 52 | 0.830 |
Why?
| | DNA Packaging | 4 | 2009 | 24 | 0.740 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 248 | 0.690 |
Why?
| | Adenosine Triphosphate | 4 | 2020 | 491 | 0.670 |
Why?
| | Models, Biological | 3 | 2024 | 1783 | 0.560 |
Why?
| | HIV-1 | 1 | 2024 | 864 | 0.560 |
Why?
| | DNA, Viral | 7 | 2020 | 364 | 0.550 |
Why?
| | Macrophages | 1 | 2024 | 1547 | 0.490 |
Why?
| | RNA, Messenger | 1 | 2023 | 2833 | 0.480 |
Why?
| | Pan troglodytes | 2 | 2025 | 63 | 0.440 |
Why?
| | Nucleocapsid | 1 | 2008 | 19 | 0.300 |
Why?
| | Receptors, Glucocorticoid | 3 | 2015 | 155 | 0.290 |
Why?
| | Capsid Proteins | 1 | 2008 | 94 | 0.280 |
Why?
| | Nucleotides | 1 | 2008 | 125 | 0.280 |
Why?
| | Endodeoxyribonucleases | 3 | 2020 | 72 | 0.270 |
Why?
| | Glycoproteins | 1 | 2008 | 342 | 0.260 |
Why?
| | Receptors, Steroid | 3 | 2015 | 50 | 0.250 |
Why?
| | Virion | 2 | 2021 | 93 | 0.240 |
Why?
| | Response Elements | 3 | 2015 | 91 | 0.240 |
Why?
| | Gorilla gorilla | 1 | 2025 | 23 | 0.230 |
Why?
| | CD4 Antigens | 1 | 2025 | 141 | 0.230 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2024 | 34 | 0.230 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2025 | 88 | 0.230 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2025 | 86 | 0.220 |
Why?
| | Viral Tropism | 1 | 2024 | 31 | 0.220 |
Why?
| | DNA Transposable Elements | 1 | 2024 | 121 | 0.210 |
Why?
| | Virus Replication | 2 | 2024 | 483 | 0.210 |
Why?
| | Promoter Regions, Genetic | 5 | 2015 | 1250 | 0.210 |
Why?
| | Delayed-Action Preparations | 1 | 2024 | 181 | 0.210 |
Why?
| | Capsid | 2 | 2020 | 93 | 0.210 |
Why?
| | Exons | 1 | 2024 | 355 | 0.210 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2024 | 104 | 0.200 |
Why?
| | Bacteriophages | 1 | 2024 | 98 | 0.200 |
Why?
| | Arterivirus | 1 | 2022 | 3 | 0.200 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 7 | 0.200 |
Why?
| | Alternative Splicing | 1 | 2024 | 229 | 0.200 |
Why?
| | Models, Chemical | 1 | 2004 | 263 | 0.190 |
Why?
| | Biomarkers | 2 | 2024 | 4149 | 0.190 |
Why?
| | DNA | 4 | 2015 | 1459 | 0.190 |
Why?
| | Adenosine Triphosphatases | 4 | 2008 | 168 | 0.180 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 30 | 0.180 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 37 | 0.180 |
Why?
| | Monocytes | 1 | 2024 | 563 | 0.170 |
Why?
| | Acute Disease | 1 | 2023 | 1007 | 0.170 |
Why?
| | Adenine Nucleotides | 1 | 2020 | 23 | 0.170 |
Why?
| | Integration Host Factors | 1 | 2020 | 13 | 0.170 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2021 | 105 | 0.160 |
Why?
| | Flow Cytometry | 1 | 2024 | 1178 | 0.160 |
Why?
| | Specimen Handling | 1 | 2021 | 183 | 0.160 |
Why?
| | Viral Load | 1 | 2021 | 466 | 0.150 |
Why?
| | Fibroblasts | 1 | 2024 | 996 | 0.150 |
Why?
| | Kinetics | 4 | 2015 | 1670 | 0.150 |
Why?
| | Universities | 1 | 2021 | 433 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1457 | 0.140 |
Why?
| | Escherichia coli Proteins | 1 | 2020 | 200 | 0.140 |
Why?
| | RNA, Viral | 1 | 2021 | 656 | 0.130 |
Why?
| | Gene Expression Profiling | 1 | 2024 | 1774 | 0.130 |
Why?
| | Vaccines | 1 | 2022 | 406 | 0.130 |
Why?
| | Viral Proteins | 4 | 2008 | 342 | 0.130 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1946 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 1991 | 0.120 |
Why?
| | Humans | 11 | 2025 | 137585 | 0.110 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 145 | 0.100 |
Why?
| | Mass Screening | 1 | 2021 | 1287 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 150 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 350 | 0.090 |
Why?
| | Thermodynamics | 4 | 2015 | 407 | 0.090 |
Why?
| | Animals | 6 | 2025 | 36940 | 0.090 |
Why?
| | Hospitalization | 1 | 2021 | 2199 | 0.090 |
Why?
| | Signal Transduction | 1 | 2024 | 5079 | 0.090 |
Why?
| | Protein Structure, Quaternary | 2 | 2008 | 128 | 0.090 |
Why?
| | Colorado | 1 | 2021 | 4565 | 0.090 |
Why?
| | Protein Binding | 5 | 2015 | 2224 | 0.080 |
Why?
| | Adenosine Diphosphate | 1 | 2009 | 79 | 0.080 |
Why?
| | Adenoviridae | 1 | 2008 | 193 | 0.070 |
Why?
| | Binding Sites | 4 | 2014 | 1303 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2607 | 0.070 |
Why?
| | Protein Isoforms | 2 | 2024 | 404 | 0.060 |
Why?
| | DNA Viruses | 1 | 2006 | 14 | 0.060 |
Why?
| | Biological Assay | 1 | 2006 | 124 | 0.060 |
Why?
| | Holoenzymes | 1 | 2005 | 24 | 0.060 |
Why?
| | Escherichia coli | 3 | 2022 | 815 | 0.060 |
Why?
| | Molecular Motor Proteins | 1 | 2005 | 45 | 0.060 |
Why?
| | Phage Therapy | 1 | 2024 | 15 | 0.060 |
Why?
| | Temperature | 2 | 2024 | 679 | 0.060 |
Why?
| | Bone Cements | 1 | 2024 | 43 | 0.050 |
Why?
| | Vanadates | 1 | 2004 | 14 | 0.050 |
Why?
| | Drug Compounding | 1 | 2024 | 101 | 0.050 |
Why?
| | Hydrolysis | 1 | 2004 | 177 | 0.050 |
Why?
| | Interferons | 1 | 2024 | 202 | 0.050 |
Why?
| | Protein Multimerization | 2 | 2015 | 192 | 0.050 |
Why?
| | Protein Subunits | 1 | 2004 | 239 | 0.050 |
Why?
| | Recombinant Proteins | 3 | 2015 | 1353 | 0.050 |
Why?
| | Macaca | 1 | 2022 | 56 | 0.050 |
Why?
| | Virus Internalization | 1 | 2022 | 49 | 0.050 |
Why?
| | Ultracentrifugation | 2 | 2015 | 52 | 0.050 |
Why?
| | Adenosine | 1 | 2004 | 225 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1502 | 0.050 |
Why?
| | Aluminum Oxide | 1 | 2022 | 13 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 730 | 0.050 |
Why?
| | Powders | 1 | 2022 | 43 | 0.050 |
Why?
| | Muramidase | 1 | 2022 | 78 | 0.050 |
Why?
| | Primates | 1 | 2022 | 126 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2024 | 828 | 0.040 |
Why?
| | DNA Footprinting | 1 | 2015 | 33 | 0.030 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 2015 | 44 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2015 | 64 | 0.030 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 570 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2024 | 1809 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2006 | 560 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1092 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2015 | 341 | 0.030 |
Why?
| | Sodium Chloride | 1 | 2013 | 142 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 665 | 0.020 |
Why?
| | Protein Conformation | 2 | 2008 | 934 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2015 | 436 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2014 | 861 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2015 | 493 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 378 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 945 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2181 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2900 | 0.020 |
Why?
| | Buffers | 1 | 2006 | 56 | 0.020 |
Why?
| | Cations, Divalent | 1 | 2006 | 52 | 0.020 |
Why?
| | Polyamines | 1 | 2006 | 40 | 0.020 |
Why?
| | Molecular Weight | 1 | 2005 | 335 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4193 | 0.010 |
Why?
| | Helix-Turn-Helix Motifs | 1 | 2002 | 5 | 0.010 |
Why?
| | Models, Genetic | 1 | 2005 | 600 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 199 | 0.010 |
Why?
| | Protein Folding | 1 | 2002 | 280 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2002 | 611 | 0.010 |
Why?
| | Nucleic Acid Conformation | 1 | 2002 | 728 | 0.010 |
Why?
| | Models, Molecular | 1 | 2002 | 1570 | 0.010 |
Why?
| | Male | 1 | 2013 | 67762 | 0.000 |
Why?
|
|
Yang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|